Inescapable footshocks induce molecular changes in the prefrontal cortex of rats in an amyloid-beta-42 model of Alzheimer's disease

Behav Brain Res. 2022 Feb 15:419:113679. doi: 10.1016/j.bbr.2021.113679. Epub 2021 Nov 24.

Abstract

Alzheimer's disease (AD) affects several brain areas, including the prefrontal cortex (PFC) involved in execution, working memory, and fear extinction. Despite these critical roles, the PFC is understudied in AD pathology. People with post-traumatic stress disorder (PTSD) have twice the risk of developing AD, and the underlying mechanisms linking these two diseases are less understood. Here, we investigated the effect of footshock stress on behavioural vis-a-vis molecular changes in the PFC of an amyloid-beta (Aβ)-42 lesion rat model of AD. Trauma-like conditions were induced by exposing the animals to several footshocks. AD-like condition was induced via intra-hippocampal injection of Aβ-42 peptide. Following Aβ-42 injections, animals were tested for behavioural changes using the Open Field Test (OFT) and Y-maze test. The PFC was later harvested for neurochemical analyses. Our results showed an interactive effect of footshocks and Aβ-42 lesion on: reduced percentage alternation in the Y-maze test, suggesting memory impairment; reduced number of line crosses and time spent in the centre square of the OFT, indicating anxiogenic responses. Similarly, there was an interactive effect of footshocks and Aβ-42 lesion on: increased FK506 binding protein 51 (FKBP5) expression, which can be associated with stress-induced anxiogenic behaviours; and increased neuronal apoptosis in the PFC of the animals. In addition, footshocks, as well as Aβ-42 lesion, reduced superoxide dismutase levels and Bridging Integrator-1 (BIN1) expression in the PFC of the animals, which can be linked to the observed memory impairment. In conclusion, our findings indicate that footshocks exaggerate PFC-associated behavioural and molecular changes induced by an AD-like pathology.

Keywords: Alzheimer’s disease; Amyloid-beta; Anxiety; Memory; Post-traumatic stress disorder; Prefrontal cortex.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / chemically induced
  • Alzheimer Disease / etiology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / physiopathology*
  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Anxiety* / chemically induced
  • Anxiety* / etiology
  • Anxiety* / metabolism
  • Anxiety* / physiopathology
  • Apoptosis* / drug effects
  • Apoptosis* / physiology
  • Behavior, Animal / drug effects
  • Behavior, Animal / physiology
  • Disease Models, Animal
  • Electroshock
  • Male
  • Memory Disorders* / chemically induced
  • Memory Disorders* / etiology
  • Memory Disorders* / metabolism
  • Memory Disorders* / physiopathology
  • Memory, Short-Term / drug effects
  • Memory, Short-Term / physiology
  • Peptide Fragments / pharmacology*
  • Prefrontal Cortex* / metabolism
  • Prefrontal Cortex* / physiopathology
  • Rats
  • Rats, Sprague-Dawley
  • Stress Disorders, Post-Traumatic* / chemically induced
  • Stress Disorders, Post-Traumatic* / etiology
  • Stress Disorders, Post-Traumatic* / metabolism
  • Stress Disorders, Post-Traumatic* / physiopathology
  • Tacrolimus Binding Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • Tacrolimus Binding Proteins
  • tacrolimus binding protein 5